We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
US-based medical device company Orthofix Medical has started commercialising its 7D FLASH Navigation System Percutaneous Module 2.0 for minimally invasive surgeries in the US. In addition, the company
US-based medical technology company Cellmyx has received the Health Canada Medical Device License (MDL) approval for its new-generation intelliFat BOD technology. The intelliFat BOD is an advanced medical
Abbott today announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) clinical study, a randomized global imaging trial. The study found that during percutaneous coronary
US-based medical technology company GE HealthCare has introduced CardioVisio for Atrial Fibrillation (AFib), its new digital decision support tool that enables precision patient care. CardioVisio is designed to
US-based organ transplant company Paragonix Technologies has received the US Food and Drug Administration (FDA) approval for BAROguard, its next-gen donor lung preservation system. BAROguard is designed to
Stimlabs LLC, (“StimLabs”), a leader in regenerative medicine, announced the launch of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for chronic and acute wounds. As the
US-based medical equipment manufacturer Sanuwave Health has agreed to merge with SEP Acquisition (SEPA), a special purpose acquisition company (SPAC), to become a publicly listed company. SEPA is
US-based non-invasive monitoring technologies provider Masimo has announced the full commercial release of its Stork smart home baby monitoring system in the US. The Stork system leverages Masimo’s
The heart teams at the Piedmont Heart Institute in Atlanta, Georgia, USA and the University of Virginia Health System in Charlottesville, VA, USA, successfully performed the first two implantations in the US
US-based medical technology company Levita Magnetics has received the US Food and Drug Administration (FDA) approval for its MARS platform. The Levita MARS system is a minimally invasive